V
Vir Biotechnology
Biotech & Life Sciences · San Francisco, United States · Founded 2016 · IPO 2019
Global footprint
Where Vir Biotechnology has talent and traffic
team presence
across markets
Talent graph
The shape of Vir Biotechnology's talent
Dealroom maps Vir Biotechnology's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$102M patent portfolio · 86 active families
Where Vir Biotechnology concentrates vs peers
Each axis is a top-10 topic across Vir Biotechnology and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Vir Biotechnology's 5 investments and acquisitions.
Every disclosed deal where Vir Biotechnology appeared as a backer or acquirer, 2017–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Vir Biotechnology's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Vir Biotechnology's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Vir Biotechnology
An AI-synthesized read of the highest-engagement posts about Vir Biotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vir Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.